Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. | Inflamm Bowel Dis | 2022 | 34918082 | PubTator, text mining | PubMed |
| Clusterin, other extracellular chaperones, and eye disease. | Prog Retin Eye Res | 2022 | 34896599 | PubTator, text mining | PubMed |
| A novel variant in TGFBI causes keratoconus in a two-generation Chinese family. | Ophthalmic Genet | 2022 | 34895010 | PubTator, text mining | PubMed |
| Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways. | Biochem Cell Biol | 2022 | 34890285 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot study. | Eur J Gastroenterol Hepatol | 2022 | 34882644 | PubTator, text mining | PubMed |
| Identification of key genes associated with papillary thyroid microcarcinoma characteristics by integrating transcriptome sequencing and weighted gene co-expression network analysis. | Gene | 2022 | 34856364 | PubTator, text mining | PubMed |
| TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer. | Hepatol Commun | 2022 | 34825776 | PubTator, text mining | PubMed |
| Up-regulation of TGFBI and TGFB2 in the plasma of gestational diabetes mellitus patients and its clinical significance. | Ir J Med Sci | 2022 | 34792732 | PubTator, text mining | PubMed |
| MiR398-regulated antioxidants contribute to Bamboo mosaic virus accumulation and symptom manifestation. | Plant Physiol | 2022 | 34695209 | PubTator, text mining | PubMed |
| Evolving cancer-niche interactions and therapeutic targets during bone metastasis. | Nat Rev Cancer | 2022 | 34611349 | PubTator, text mining | PubMed |
| The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma. | Cancer Gene Ther | 2022 | 34548635 | PubTator, text mining | PubMed |
| Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration. | Curr Neuropharmacol | 2022 | 34414870 | PubTator, text mining | PubMed |
| Torin 1 alleviates impairment of TFEB-mediated lysosomal biogenesis and autophagy in TGFBI (p.G623_H626del)-linked Thiel-Behnke corneal dystrophy. | Autophagy | 2022 | 34403298 | PubTator, text mining | PubMed |
| Yeast Ssd1 is a non-enzymatic member of the RNase II family with an alternative RNA recognition site. | Nucleic Acids Res | 2022 | 34302485 | PubTator, text mining | PubMed |
| Pediatric sepsis biomarkers for prognostic and predictive enrichment. | Pediatr Res | 2022 | 34127800 | PubTator, text mining | PubMed |
| Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos. | Stem Cell Rev Rep | 2022 | 33904115 | PubTator, text mining | PubMed |
| A novel missense TGFBI variant p.(Ser591Phe) in a Finnish family with variant lattice corneal dystrophy. | Eur J Ophthalmol | 2022 | 33645289 | PubTator, text mining | PubMed |
| Human obese white adipose tissue sheds depot-specific extracellular vesicles and reveals candidate biomarkers for monitoring obesity and its comorbidities. | Transl Res | 2022 | 33465489 | PubTator, text mining | PubMed |
| Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. | Explor Target Antitumor Ther | 2021 | 36046090 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from head and neck squamous cells carcinoma inhibit NLRP3 inflammasomes. | Curr Res Immunol | 2021 | 35492395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=53